INTRODUCTION {#S1}
============

The first living cells appeared on Earth \~4 billion years ago in an oxygen-deficient environment ([@R34]). To sustain anaerobic life, primeval cells generated energy (ATP) through early forms of glycolysis, a highly conserved core component of central carbon metabolism that exists in virtually all extant species ([@R14]). The polypeptides required to catalyze these primordial metabolic reactions were synthesized by two core ancient translation factors: initiation factor 1 (IF1) and IF2 ([@R14]). After 1.5 billion years of anaerobic evolution, the increase in atmospheric oxygen catalyzed an upsurge in cellular energy production and biochemical complexity exempli fied by contemporary eukaryotes ([@R5]; [@R24]). The eukaryotic protein synthesis machinery is a paragon of this expansion of complexity. For initiation alone, eukaryotic cells employ at least 13 core eukaryotic-specific translation initiation factors (eIFs) composed of 33 known subunits ([@R13]), highlighting the significance of aerobic protein synthesis to modern eukaryotic life. Yet the ancestral IF2, which can be traced back to the last universal common ancestor (LUCA), remains conserved in eukaryotes as eIF5B ([@R3]; [@R18]), just as it is in bacteria (IF2) and archaea (aIF2) ([@R4]). Despite such strong evolutionary conservation, however, eIF5B is not essential in eukaryotes under basal conditions, exhibiting minimal effects on global translation and cell viability ([@R3]; [@R31]). These observations raise the intriguing possibility that eIF5B/IF2, which first evolved in the absence of oxygen, was retained during aerobic eukaryotic evolution as a mechanism to sustain protein synthesis during oxygen deficiency.

In prokaryotes, IF2 facilitates initiator formylated met-tRNA^fMet^ delivery to ribosomes ([@R17]; [@R36]). In contrast, this task is typically accomplished in eukaryotes by the textbook eIF2 that delivers met-tRNAi^Met^ to the 40S ribosomal subunit ([@R13]; [@R29]). eIF2 function is tightly regulated by the integrated stress response (ISR), a ubiquitous eukaryotic program activated by various environmental stresses, including hypoxia ([@R8]; [@R21]; [@R35]). During hypoxic episodes, ISR-inducible kinases phosphorylate the eIF2α subunit and inhibit eIF2 activity ([@R19]). Although ISR-mediated eIF2 inhibition should theoretically abolish translation initiation, hypoxic cells are capable of engaging in robust cap-dependent protein synthesis by eIF4F^H^, the functional counterpart of the normoxic eIF4F ([@R11]; [@R19]; [@R32]). These data suggest that another translation initiation factor may complement, or assist, in the delivery of met-tRNAi^Met^ for eIF4F^H^-directed translation during periods of hypoxic eIF2 inactivation.

In this study, we report that hypoxic cells exhibit increased dependence on eIF5B/IF2 for translation initiation and cell survival, with central carbon metabolism (CCM) being a major eIF5B-dependent target. A number of these targets rely preferentially on eIF5B, regardless of eIF2 activity. We suggest that during aerobic eukaryotic evolution, metabolic pathways that first evolved under anaerobic conditions retained their reliance on eIF5B/IF2, which remains active during oxygen deprivation.

RESULTS {#S2}
=======

MATRIX Identifies eIF5B as a Hypoxia-Enriched Translation Factor {#S3}
----------------------------------------------------------------

The ancient eIF5B/IF2 likely evolved in an anaerobic environment. We hypothesized that eIF5B retains the ability to operate in eukaryotic cells exposed to low oxygen ([Figure S1A](#SD1){ref-type="supplementary-material"}), a stress that inactivates the canonical eIF2. To test this hypothesis impartially, we developed a method to assess global translation factor activity in living cells, termed MATRIX (mass spectrometry analysis of active translation factors using ribosome density fractionation and isotopic labeling experiments) ([Figure 1A](#F1){ref-type="fig"}). Integrating metabolic pulse labeling, ribosome density fractionation, and high-throughput mass spectrometry, MATRIX offers the capability to generate an architectural blueprint of biologically active cellular translational machineries. Ribosome density fractionation effectively separates cellular assets based on translational activity. Specifically, factors actively engaged in protein synthesis are preferentially enriched in polysome fractions, while those disengaged from active translation are relatively consigned to the free fractions. We also analyzed ribosomal 40/60/80S fractions, which allow us to assess factors involved in translation initiation more specifically. Oligosome (mild translation) fractions were excluded from analysis because of the ambiguous or transitional state of protein synthesis that they represent. To minimize the confounding presence of newly synthesized peptides and proteins, cells grown in light stable isotope labeling by amino acids in cell culture (SILAC) media were pulsed with heavy SILAC media before protein harvest. This allows us to identify and exclude from further analysis peptides derived from ongoing translation.

We performed MATRIX on U87MG glioblastoma cells subjected to normoxia (21% O~2~) and hypoxia (1% O~2~), a concentration that simultaneously activates eIF4F^H^ and inhibits eIF4F ([Figure 1B](#F1){ref-type="fig"}) ([@R11]; [@R32]). The ratio of peptide/protein abundance in polysome fractions (active, intense translation) to free fractions (translationally disengaged) was used as the primary readout ([Figure 1B](#F1){ref-type="fig"}, left panel). The abundance ratio of proteins engaged in translation initiation (40/60/80S fractions) to free fractions served as a secondary readout ([Figure 1B](#F1){ref-type="fig"}, right panel). Overall, MATRIX detected 2,728 well-represented (≥5 unique peptides) cellular factors ([Table S1](#SD1){ref-type="supplementary-material"}). We identified 30 translation factors with high confidence (i.e., detected across all measured fractions, ≥25% protein coverage). Based on the previously mentioned readouts, and an enrichment criterion of ≥2× mean fold change after outlier removal, MATRIX identified eIF5B (3× enrichment) ([Figure 1B](#F1){ref-type="fig"}, blue highlight) as one of two translation factors (the other being eIF4B) that exhibited augmented activity under hypoxic conditions. Reassuringly, this impartial analysis confirmed the well-established hypoxic inhibition of eIF2α activity (2× decrease) ([Figure 1B](#F1){ref-type="fig"}, red highlight). These findings were validated by immunoblot analysis of ribosome density fractions ([Figure 1C](#F1){ref-type="fig"}). Thus, MATRIX analysis revealed that eIF5B concentrates in hypoxic translating ribosomes.

Involvement of eIF5B in Hypoxic Protein Synthesis {#S4}
-------------------------------------------------

Next, we examined the effect of eIF5B depletion on global protein synthesis in various human cell lines exposed to normoxia or hypoxia using ribosome density profiling ([Figures 1D](#F1){ref-type="fig"} and [S1B](#SD1){ref-type="supplementary-material"}). Normoxic eIF5B-depleted cells exhibited a modified ribosome density profile but maintained a largely similar translational intensity, as determined by quantitative area under curve measurements ([Figures 1D](#F1){ref-type="fig"}, left panel, and [S1C](#SD1){ref-type="supplementary-material"}, top panel). In contrast, eIF5B-silencing in hypoxic cells resulted in a \~35% loss in translating ribosomes and decreased translational capacity ([Figures 1D](#F1){ref-type="fig"}, right panel, and [S1C](#SD1){ref-type="supplementary-material"}, bottom panel). Similarly, puromycin incorporation showed that eIF5B silencing produced little discernable effect on normoxic translational capacity across multiple cell lines, while global translation was reproducibly decreased by \~40% in eIF5B-depleted hypoxic cells ([Figures 1E](#F1){ref-type="fig"} and [S1D](#SD1){ref-type="supplementary-material"}). These findings agree with published observations that eIF5B is basally non-essential. Normoxic eIF5B depletion resulted only in a modest suppression of cell growth and viability ([Figures 1F](#F1){ref-type="fig"} and [1G](#F1){ref-type="fig"}). In contrast, hypoxic cell viability was significantly decreased by eIF5B silencing ([Figures 1F](#F1){ref-type="fig"} and [1G](#F1){ref-type="fig"}).

eIF5B Facilitates met-tRNAi^Met^ Delivery during Hypoxia {#S5}
--------------------------------------------------------

eIF2 is the paradigmatic translation initiation factor that delivers met-tRNAi^Met^ to eukaryotic ribosomes. As the affinity of eIF5B for met-tRNAi^Met^ is considerably lower than that of eIF2, several studies have suggested a role for this translation factor in 80S ribosomal subunit joining ([@R23]; [@R30]). Confirming the observation that eIF5B was functionally enriched in hypoxic translating ribosomes ([Figure 1B](#F1){ref-type="fig"}), we observed increased association between eIF5B and tRNAi^Met^ in hypoxic versus normoxic conditions ([Figures 2A](#F2){ref-type="fig"} and [S2A](#SD1){ref-type="supplementary-material"}). Likewise, eIF5B silencing caused a decrease in tRNAi^Met^ levels in hypoxic ribosomes compared to eIF5B-replete controls ([Figure 2B](#F2){ref-type="fig"}), unlike elongating tRNAs, such as tRNA^Arg^, which remained unaffected ([Figure S2B](#SD1){ref-type="supplementary-material"}). This hypoxic augmentation of eIF5B activity may be accounted for, at least partly, by increased met-tRNAi^Met^ availability as a result of eIF2 inhibition. Hypoxia-induced eIF2α subunit phosphorylation and eIF2 inactivation correlate positively with the induction of both ATF4, a master transcription factor of ISR induced regardless of initiating stress ([@R21]), and NDRG1, a hypoxia-inducible protein ([@R11]) ([Figure 2C](#F2){ref-type="fig"}). This suggested that the synthesis of hypoxia-inducible proteins is eIF2 independent, instead relying on alternative factors to deliver met-tRNAi^Met^. eIF5B silencing severely attenuated the hypoxic induction of ATF4 and NDRG1 ([Figures 2D](#F2){ref-type="fig"} and [S2C](#SD1){ref-type="supplementary-material"}, left panels) due to reduced translation efficiency (TE) ([Figure 2E](#F2){ref-type="fig"}), but not steady-state levels of mRNAs ([Figure S2D](#SD1){ref-type="supplementary-material"}). Such hypoxic induction remained eIF5B dependent and eIF2 independent even following treatment with salubrinal, an ISR-prolonging eIF2 phosphatase inhibitor ([@R1]) ([Figures 2D](#F2){ref-type="fig"} and [S2C](#SD1){ref-type="supplementary-material"}, middle panels). Tunicamycin-induced endoplasmic reticulum (ER) stress, which leads to rapid eIF2α phosphorylation or eIF2 inactivation ([@R9]), resulted in robust eIF5B-independent accumulation of the pan-stress-inducible ATF4, but not the hypoxia-induced protein NDRG1 ([Figures 2D](#F2){ref-type="fig"} and [S2C](#SD1){ref-type="supplementary-material"}, right panels). Furthermore, cellular translational dependence on eIF5B was unaffected by heat shock ([Figure S2E](#SD1){ref-type="supplementary-material"}). These data suggested that eIF5B is preferentially regulated by hypoxic stress.

We next examined the relationship between eIF5B-dependent met-tRNAi^Met^ delivery and eIF2 activity status. In certain cellular systems, prolonged hypoxia is associated with ISR recovery and eIF2 reactivation (via eIF2α dephosphorylation) ([Figures 2F](#F2){ref-type="fig"} and [S2F](#SD1){ref-type="supplementary-material"}) ([@R15]). Yet the induction of classic hypoxia-inducible proteins, such as NDRG1 and glucose transporter GLUT1/SLC2A1, under prolonged hypoxia remained eIF5B dependent but eIF2 independent, even with tunicamycin- or salubrinal-induced augmentation of eIF2 inhibition ([Figures 2G](#F2){ref-type="fig"}, [S2G](#SD1){ref-type="supplementary-material"}, and [S2H](#SD1){ref-type="supplementary-material"}). We were mindful of the possibility that residual eIF2α phosphorylation under prolonged hypoxia could preclude full reactivation of eIF2 activity ([Figure 2F](#F2){ref-type="fig"}). To address this issue, we employed the 786-0 clear cell renal cell carcinoma cell model, which behaves as a pseudo-hypoxic system under basal, normoxic conditions due to the genetic loss of von Hippel-Lindau (VHL). As such, normoxic 786-0 engages simultaneously in both normoxic and hypoxic protein synthesis ([@R11]). This represents an ideal model system to examine basal, normoxic eIF2 and eIF5B activities without the need for hypoxic stimulation. Results indicated that eIF5B silencing markedly reduced eIF5B-dependent NDRG1 and GLUT1 protein levels ([Figures 2H](#F2){ref-type="fig"} and [S2I](#SD1){ref-type="supplementary-material"}), as well as global protein synthesis in normoxic 786-0 ([Figure 2I](#F2){ref-type="fig"}). Again, eIF5B-dependent targets demonstrated eIF2 independence even in normoxic 786-0 ([Figures 2J](#F2){ref-type="fig"} and [S2J](#SD1){ref-type="supplementary-material"}). These data suggest that eIF5B may act as the hypoxic surrogate of eIF2 through direct met-tRNAi^Met^ delivery to initiating ribosomes and/or through ribosomal subunit joining. The relative contributions of various eIF5B activities to its role in hypoxic translation, e.g., met-tRNAi^Met^ recruitment, GTPase activity, and ribosomal subunit joining ([@R27]), remain to be determined in future studies. The translation factors eIF2A and eIF2D can assemble with met-tRNAi^Met^ under specific conditions ([@R26]). However, eIF2A and eIF2D silencing did not significantly alter ribosome density profiles ([Figures 2K](#F2){ref-type="fig"} and [S2K](#SD1){ref-type="supplementary-material"}) or global protein synthesis ([Figure S2L](#SD1){ref-type="supplementary-material"}), and we observed no accumulation of these factors in actively translating hypoxic ribosomes ([Figure 2L](#F2){ref-type="fig"}).

Global Interrogation of eIF5B-Dependent Translatome Remodeling {#S6}
--------------------------------------------------------------

Next, we sought to determine the eIF5B-dependent target population in hypoxic cells using an unbiased, integrative approach that combines high-throughput RNomic and proteomic analyses, enabling the assessment of steady-state RNA and protein levels and translational output (TE/protein output) from the same samples, respectively ([Figure 3A](#F3){ref-type="fig"}). Consistent with our biochemical assays ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}), RNomic analysis revealed a global decrease in TE ([Figure S3A](#SD1){ref-type="supplementary-material"}) for more than 70% of detected mRNAs in eIF5B-depleted cells compared to controls ([Figure 3B](#F3){ref-type="fig"}, top panel), with minimal correlation with RNA level changes ([Figure 3B](#F3){ref-type="fig"}, bottom panel). The high sensitivity of this assay allowed us to detect many low-abundance mRNAs whose TE changes were likely masked by global-scale assessments ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}). Complementary to RNA-based translatome analysis ([@R6]; [@R11]; [@R12]), live-cell metabolic labeling by pulse-SILAC (pSILAC)-mass spectrometry (MS) represents a reliable, direct readout for global translational output ([@R25]). Our pSILAC-MS analysis identified 480 proteins that exhibited reduced protein synthesis in eIF5B-depleted hypoxic cells ([Figures 3C](#F3){ref-type="fig"} and [S3B](#SD1){ref-type="supplementary-material"}; [Table S2](#SD1){ref-type="supplementary-material"}). Translational output of these proteins exhibited significant positive correlation with steady-state protein levels ([Figure 3C](#F3){ref-type="fig"}), and most (85%) demonstrated corresponding decreases in TE, but not RNA levels ([Figures 3D](#F3){ref-type="fig"} and [S3B](#SD1){ref-type="supplementary-material"}).

We recently defined a class of eIF4F^H^-dependent cellular mRNAs that are translationally enhanced under hypoxic conditions, termed class III ([@R11]). Class III members were more profoundly affected by eIF5B in terms of both magnitude ([Figure 3E](#F3){ref-type="fig"}) and proportion (2× enrichment) ([Figure 3F](#F3){ref-type="fig"}) compared to class I (translationally downregulated during hypoxia) and class II (translation unaffected by oxygen levels). Protein output in eIF5B-depleted cells showed significant positive correlation with steady-state protein levels across all three classes ([Figure S3C](#SD1){ref-type="supplementary-material"}). Altogether, these studies identified a sizable eIF5B-dependent target population and provide evidence for eIF5B as an essential component of the hypoxic protein synthesis machinery.

Central Carbon Metabolism Is a Major eIF5B-Dependent Target {#S7}
-----------------------------------------------------------

Pathway enrichment analysis revealed the ancient pathways of central carbon metabolism and cellular hypoxic response as some of the most prominent eIF5B-dependent systems ([Figures 4A](#F4){ref-type="fig"}, [S4A](#SD1){ref-type="supplementary-material"}, and [S4B](#SD1){ref-type="supplementary-material"}). Multi-dimensional validation confirms concordant changes in TE, protein output, and steady-state protein levels for each identified eIF5B target ([Figures 4A](#F4){ref-type="fig"}, bottom panel; [4B](#F4){ref-type="fig"}; and [S4B](#SD1){ref-type="supplementary-material"}, bottom panel). The observation that most eIF5B-dependent proteins are class III members ([Figure S4C](#SD1){ref-type="supplementary-material"}) highlights the critical involvement of eIF5B in adaptive hypoxic translatome reprogramming. The number of eIF5B-dependent enzymes and proteins involved in central carbon metabolism and fructolysis demonstrates the vital eIF5B dependence of these pathways ([Figures 4C](#F4){ref-type="fig"} and [S4D](#SD1){ref-type="supplementary-material"}). Unlike proteins involved in hypoxic adaptation ([Figure 4D](#F4){ref-type="fig"}), proteins implicated in other cellular stresses, e.g., heat shock (Hsp27, Hsp70, and Hsp90), appear to be eIF5B independent, at least in our system ([Figures S4E--S4G](#SD1){ref-type="supplementary-material"}). In addition, hypoxia-inducible factor (HIF) alpha subunits HIF-1α and HIF-2α, which orchestrate the transcriptional ([@R33]) and translational ([@R32]) arms of the conserved cellular hypoxic response, exhibited notable eIF5B dependence ([Figures 1E](#F1){ref-type="fig"}, [4A](#F4){ref-type="fig"}, [4D](#F4){ref-type="fig"}, [S1D, S2C, and S2E--S2G](#SD1){ref-type="supplementary-material"}). These findings underscore the unique role of eIF5B in hypoxic adaptation. Central carbon metabolism is a vital pathway that operates at a minimal basal level under normoxic conditions. Quantification of normoxic immunoblots revealed the eIF5B dependence of these pathways (e.g., GLUT1 and NDRG1) even under standard, normoxic conditions ([Figures 2D](#F2){ref-type="fig"} and [2G](#F2){ref-type="fig"}), including in normoxic 786-0 ([Figures 2H](#F2){ref-type="fig"} and [2J](#F2){ref-type="fig"}). Finally, we confirmed the normoxic dependence of central carbon metabolism on eIF5B using a global pSILAC assessment of protein output in eIF5B-depleted, normoxic 786-0 ([Figure 4E](#F4){ref-type="fig"}).

DISCUSSION {#S8}
==========

In this report, we provide evidence that eIF5B is a key element of the cellular hypoxic protein synthesis machinery. Systemic translatome analyses revealed that eIF5B is principally involved in the translation of proteins involved in the ancient central carbon metabolism and cellular hypoxic response pathways. In addition, eIF5B is required for hypoxic cells to mount an ATF4-mediated stress response. It is tempting to speculate that eIF5B/IF2 was retained throughout the aerobic eukaryotic lineage to synthesize proteins that ensure cellular survival in oxygen-deficient environments, thus explaining their conservation to LUCA and across all domains of life. In addition, translatome analysis suggests that the HIF-2α and eIF4F^H^-dependent class III mRNAs ([@R11]; [@R32]) rely mostly on eIF5B, even when eIF2 is active. These data suggest that eIF5B facilitates met-tRNAi^Met^ delivery for eIF4F^H^-mediated hypoxic cap-dependent translation.

From a broader perspective, our findings provide further evidence for the emerging paradigm of alternative, stress-specific translation machineries, such as the hypoxic cap-binding complex eIF4F^H^ ([@R10]; [@R11]; [@R16]; [@R32]). Our current study expands upon this concept by demonstrating the hypoxic activation of eIF5B that may operate like eIF2A under certain eIF2-inactivating conditions ([@R26]).

Hypoxic augmentation of eIF5B activity was revealed by MATRIX, a global, unbiased approach that we developed to assess translation factor usage in living cells. Biological activity is a cornerstone of MATRIX, which prioritizes the ability to distinguish actively engaged translation factors from their disengaged or underused counterparts, especially across conditions. This feature offers MATRIX the innovative capability to reveal the lineup of active translation factors. This contrasts with studies that provide the roster or catalog of cellular factors, such as RNA-binding proteins ([@R2]) and ribosome-associated proteins ([@R28]). Synergistic utilization of these complementary approaches could yield deeper insight into fundamental cellular processes, such as translation. We focused our current MATRIX analysis on known translation factors. Beyond these, MATRIX identified \>70 ribosomal proteins, \>40 recognized RNA-binding proteins, and many additional factors. Future studies are required to examine the biological roles of these factors.

Our studies demonstrate that central carbon metabolism is intricately dependent on eIF5B during normoxia and especially hypoxia. Oxygen-dependent oxidative phosphorylation is the primary mechanism of cellular energy generation in aerobic eukaryotes. Because hypoxia inhibits this process, hypoxic cells engage in a complex, coordinated effort to augment central carbon metabolism (glucose intake, glycolysis, and trichloroacetic acid \[TCA\] cycle) to meet energy demands. In contrast, basal central carbon metabolism functions at a lower level under standard, normoxic conditions. This difference in central carbon metabolism activity or requirement may explain the increased eIF5B dependence of translation initiation and cell viability during hypoxia, as well as the non-essentiality of eIF5B under basal normoxic conditions ([@R3]; [@R31]). Our data suggest that eIF5B enables the hypoxia-induced glycolytic switch ([@R20]). Therapeutically, enhancing normoxic eIF5B activity to augment aerobic glycolysis may benefit Leigh syndrome patients who suffer from defective oxidative phosphorylation. Conversely, eIF5B inhibition represents a potential anti-cancer therapy given that aerobic glycolysis, or the Warburg effect, is a hallmark of cancer ([@R7]).

Finally, there exist eukaryotic species that can subsist in low-oxygen conditions, e.g., naked mole rats ([@R22]) and humans living at high altitude (e.g., Tibetan highlanders) ([@R37]). It will be interesting to determine in future studies any differences in eIF5B dependence or utilization between hypoxia-tolerant and hypoxia-intolerant species and/or populations.

EXPERIMENTAL PROCEDURES {#S9}
=======================

Cell Culture and Reagents {#S10}
-------------------------

U87MG, MCF7, and A549 cells were obtained from ATCC and propagated in DMEM (HyClone) with 10% fetal bovine serum (FBS) (Omega Scientific) and 1% penicillin-streptomycin (Pen-Strep) (HyClone). Cells were maintained at 37 C in a 5% CO~2~ humidified incubator. Cells were subjected to hypoxia (1% O~2~, 24 hr unless otherwise stated) at 37 C in a 5% CO~2~, N~2~-balanced, humidified H35 HypOxystation (HypOxygen). Final treatment concentrations were cycloheximide (Amresco) at 0.2 mg/mL, 75 μM salubrinal (Sigma-Aldrich) for 4 hr, and 25 μM tunicamycin (Sigma-Aldrich) for 4 hr.

SILAC {#S11}
-----

Cells were grown in light (R~0~K~0~) SILAC media (AthenaES) for 7 days before treatment. For MATRIX analysis, cells were pulsed with heavy (R~10~K~8~) SILAC media (AthenaES) for 4 hr (MATRIX) or 16 hr (pSILAC) following treatment.

Ribosome Density Fractionation {#S12}
------------------------------

Polyribosome fractionations were performed essentially as previously described ([@R11]). Samples loaded based on equal cell number or equal total RNA yielded similar results. Total RNA was isolated from each fraction by phenol or chloroform extraction and ethanol precipitation following proteinase K treatment. Total protein was isolated by TCA precipitation.

MS Analysis {#S13}
-----------

Liquid chromatography-tandem MS was performed by the SPARC BioCentre (The Hospital for Sick Children, Toronto, Canada). More details are provided in [Supplemental Information](#SD1){ref-type="supplementary-material"}.

RNA Sequencing Analysis {#S14}
-----------------------

Poly(A) RNA selection was performed before library preparation and RNA sequencing runs. More details are provided in [Supplemental Information](#SD1){ref-type="supplementary-material"}.

Statistical Analysis {#S15}
--------------------

All experiments were performed at least three independent times, unless otherwise stated. Appropriate statistical analyses were performed, including Student's t tests, Pearson's correlation coefficient (ρ) calculations with 95% confidence intervals and p values, and chi-square tests, to investigate proportional differences. Statistical significance was defined as p \< 0.05.
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======================

S.L. is funded by grants from the NIH (NIGMS, 1R01GM115342, and NCI, 1R01CA200676) and the Sylvester Comprehensive Cancer Center. J.J.D.H. is a recipient of a Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship. We thank Dr. Siôn Ll. Williams and Dr. Steven Chen from the Sylvester Comprehensive Cancer Center Oncogenomics Core Facility and Biostatistics and Bioinformatics Core Facility, respectively, for RNA sequencing and analysis services.

**DATA AND SOFTWARE AVAILABILITY**

The accession number for the MS datasets reported in this paper is ProteomeXchange: PXD006799. The accession number for the RNA sequencing datasets reported in this paper is SRA: SRP110475.

**SUPPLEMENTAL INFORMATION**

[Supplemental Information](#SD1){ref-type="supplementary-material"} includes [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"}, four figures, and two tables and can be found with this article online at <https://doi.org/10.1016/j.celrep.2017.12.031>.

**AUTHOR CONTRIBUTIONS**

J.J.D.H. and S.L. conceptualized the study and MATRIX. J.J.D.H. and S.L. conceived the experiments. J.J.D.H., N.C.B., G.C., P.D.M., and J.R.K. performed the experiments. J.J.D.H., N.C.B., J.R.K., and S.L. analyzed the data. J.J.D.H. and S.L. wrote the manuscript.

**DECLARATION OF INTERESTS**

The authors declare no competing interests.

![MATRIX Identifies eIF5B as a Hypoxia-Enriched Translation Factor\
(A) MATRIX workflow.\
(B) MATRIX analysis of eukaryotic translation factor activity in hypoxic versus normoxic protein synthesis in U87MG. Ratios of peptide/protein abundance in polysome to free fractions (left panel) and 40/60/80S to free fractions (right panel) were calculated.\
(C) MATRIX validation by immunoblot in normoxic and hypoxic U87MG. Representative immunoblots are shown. Mono, monosome (40/60/80S); oligo, oligosome; poly, polysome.\
(D and E) Ribosome density profiling (D) and representative immunoblots (E) of normoxic and hypoxic U87MG treated with control non-silencing (NS) or eIF5B-specific small interfering RNA (siRNA).\
(F and G) Fluorescein diacetate (FDA) staining (F, green) with DAPI counterstaining (F, inset, blue) and cell viability measurements (G) were performed in normoxic and hypoxic U87MG treated with NS or eIF5B-specific siRNA.\
Error bars represent SEM. \*p \< 0.05. See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms934751f1){#F1}

![eIF5B Facilitates eIF2-Independent met-tRNAi^Met^ Delivery\
(A) eIF5B RNA immunoprecipitations (RIPs) followed by qRT-PCR measurements of input-normalized tRNAi^Met^ levels from normoxic and hypoxic U87MG.\
(B) Normoxic and hypoxic U87MG treated with control non-silencing (NS) or eIF5B-specific siRNA were subjected to ribosome density fractionation, followed by qRT-PCR measurements of tRNAi^Met^ levels in the indicated fractions. (C and D) Representative immunoblots of hypoxic U87MG (C) and normoxic and hypoxic (1% O~2~, 10 hr) U87MG (D) treated with NS or eIF5B-specific siRNA (left panel) and with salubrinal (middle panel) or tunicamycin (right panel).\
(E) Normoxic and hypoxic U87MG treated with NS or eIF5B-specific siRNA were subjected to ribosome density fractionation, followed by mRNA level measurements by qRT-PCR. Translation efficiency was defined as the ratio of polysome to monosome abundance.\
(F--H) Representative immunoblots of hypoxic U87MG (F), normoxic and hypoxic U87MG treated with NS or eIF5B-specific siRNA and tunicamycin (G), and normoxic 786-0 treated with NS or eIF5B-specific siRNA (H).\
(I) Puromycin incorporation measurements (left panel) and representative immunoblot (right panel) in normoxic 786-0 treated with NS or eIF5B-specific siRNA.\
(J) Representative immunoblots of normoxic 786-0 treated with NS or eIF5B-specific siRNA and tunicamycin.\
(K) Ribosome density profiling of hypoxic U87MG treated with NS, eIF2A-specific (left panel), or eIF2D-specific (right panel) siRNA. Area under curve measurements (area) are shown.\
(L) Representative immunoblots of normoxic and hypoxic U87MG subjected to ribosome density fractionation.\
Mono, monosome (40/60/80S); oligo, oligosome; poly, polysome. Error bars represent SEM. \*p \< 0.05. See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms934751f2){#F2}

![Global Interrogation of eIF5B-Dependent Targets\
(A) Workflow of RNomic and proteomic analyses.\
(B) RNomic analysis of translation efficiency (TE) and steady-state RNA levels. Transcripts exhibiting decreased TE (≤0.5-fold) are highlighted in red.\
(C) eIF5B-dependent targets that exhibit decreased TE, protein output, and steady-state protein levels (≤0.75-fold).\
(D) Agreement between TE, steady-state RNA level and protein output.\
(E) Effect of eIF5B depletion on magnitude of TE decrease across hypoxia-responsive mRNA classes.\
(F) Proportions of the three hypoxia-responsive mRNA classes under eIF5B-replete and eIF5B-depleted (by siRNA) conditions.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms934751f3){#F3}

![Central Carbon Metabolism Is a Major eIF5B-Dependent Pathway\
(A) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of eIF5B-dependent cellular processes (top panel). Hexagon models depicting TE, steady-state RNA level, protein output, and steady-state protein level for each identified protein involved in central carbon metabolism and hypoxic adaptation are shown (bottom panel).\
(B) Legend for models in Figures 4A and [S4A](#SD1){ref-type="supplementary-material"}.\
(C) eIF5B-dependent enzymes and proteins of central carbon metabolism and fructolysis identified by protein output and/or TE analyses. The asterisk indicates additional identified enzymes and/or isoforms ([Figure S4D](#SD1){ref-type="supplementary-material"}).\
(D) Representative immunoblots of eIF5B-dependent proteins from normoxic and hypoxic U87MG treated with non-silencing (NS) control or eIF5B-specific siRNA.\
(E) pSILAC analysis of protein output in normoxic 786-0 treated with NS or eIF5B-specific siRNA.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms934751f4){#F4}

###### Highlights

-   MATRIX produces system-wide blueprints of active translation factors

-   eIF5B is an essential component of the hypoxic protein synthesis machinery

-   eIF5B is the hypoxic surrogate of eIF2 that facilitates met-tRNAi^Met^ delivery

-   Central carbon metabolism proteins are principally reliant on eIF5B for translation
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